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Patients with hormone-resistant prostate cancer (PCa) have higher biochemical 
failure rates following radiation therapy (RT). Cyclin D1 deregulated expression in 
PCa is associated with a more aggressive disease: however its role in radioresistance 
has not been determined. Cyclin D1 levels in the androgen-independent PC3 and 
22Rv1 PCa cells were stably inhibited by infecting with cyclin D1-shRNA. Tumori-
genicity and radiosensitivity were investigated using in vitro and in vivo experimen-
tal assays. Cyclin D1 silencing interfered with PCa oncogenic phenotype by induc-
ing growth arrest in the G1 phase of cell cycle and reducing soft agar colony forma-
tion, migration, invasion in vitro and tumor formation and neo-angiogenesis in vivo. 
Depletion of cyclin D1 significantly radiosensitizes PCa cells by increasing the RT-
induced DNA damages by affecting the NHEJ and HR pathways responsible of the 
DNA double-strand break repair. Following treatment of cells with RT the abundance 
of a biomarker of DNA damage, γ-H2AX, was dramatically increased in sh-cyclin D1 
treated cells compared to shRNA control. Concordant with these observations DNA-
PKcs-activation and RAD51-accumulation, part of the DNA double-strand break 
repair machinery, were reduced in shRNA-cyclin D1 treated cells compared to shR-
NA control. We further demonstrate the physical interaction between CCND1 with 
activated-ATM, -DNA-PKcs and RAD51 is enhanced by RT. Finally, siRNA-mediated 
silencing experiments indicated DNA-PKcs and RAD51 are downstream targets of 
CCND1-mediated PCa cells radioresistance. In summary, these observations suggest 
that CCND1 is a key mediator of PCa radioresistance and could represent a potential 
target for radioresistant hormone-resistant PCa.
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